Donald Mahoney
Overview
Explore the profile of Donald Mahoney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen D, Grimes A, Mahoney D, Faro S, Shearer W, Miller A, et al.
Front Pediatr
. 2021 Jul;
9:648022.
PMID: 34307247
Nuclear factor κappa-B (NFκB) is a family of transcription factors involved in regulating inflammation and immunity. Mutations in the pathway are associated with primary immune defects and underlie the most...
2.
Diaz R, Musso M, Mahoney D
Pediatr Hematol Oncol
. 2020 Aug;
38(1):25-35.
PMID: 32804010
Introduction: Children with low von Willebrand factor (VWF) activity or type 1 von Willebrand disease (VWD) have increased risk of bleeding after adenotonsillar procedures and the optimal perioperative management to...
3.
Dinh C, Moffett B, Galati M, Lee-Kim Y, Yee D, Mahoney D
J Pediatr Pharmacol Ther
. 2019 Apr;
24(2):128-133.
PMID: 31019405
Objectives: The purposes of this study are to perform a large-scale evaluation of the standardized dosage adjustment nomogram recommended by the American College of Chest Physicians (CHEST) for the management...
4.
Moffett B, Lee-Kim Y, Galati M, Mahoney D, Shah M, Teruya J, et al.
Ann Pharmacother
. 2017 Oct;
52(2):140-146.
PMID: 28962537
Background: There are no studies evaluating the pharmacokinetics of enoxaparin in the hospitalized pediatric patient population. Objective: To characterize the pharmacokinetics of enoxaparin in pediatric patients. Methods: A retrospective review...
5.
Moffett B, Galati M, Mahoney D, Lee-Kim Y, Teruya J, Shah M, et al.
Ther Drug Monit
. 2017 Sep;
39(6):632-639.
PMID: 28937536
Aims: Enoxaparin dosing requirements in the first year of life can be highly variable. Characterization of pharmacokinetics in this patient population can assist in dosing. Methods: Patients less than 1...
6.
Glogowska E, Schneider E, Maksimova Y, Schulz V, Lezon-Geyda K, Wu J, et al.
Blood
. 2017 Jul;
130(16):1845-1856.
PMID: 28716860
Mutations in PIEZO1 are the primary cause of hereditary xerocytosis, a clinically heterogeneous, dominantly inherited disorder of erythrocyte dehydration. We used next-generation sequencing-based techniques to identify mutations in individuals from...
7.
Moffett B, Diaz R, Galati M, Mahoney D, Teruya J, Yee D
Br J Clin Pharmacol
. 2017 Jul;
83(11):2450-2457.
PMID: 28664670
Aims: Antithrombin is increasingly used in paediatric patients, yet there are few age-specific pharmacokinetic data to guide dosing. We aimed to describe the pharmacokinetic profile of human (plasma-derived) antithrombin concentrate...
8.
Dietrich J, Yee D, Santos X, Bercaw-Pratt J, Kurkowski J, Soni H, et al.
J Pediatr Adolesc Gynecol
. 2016 Oct;
30(2):243-246.
PMID: 27751907
Results: Twenty-three of 45 subjects completed the study. The mean age was 14.1 ± 1.9 years. Subjects who were compliant with the ITD (group 1), charted on baseline symptoms, menstrual...
9.
Gajudhur J, Slone J, Mehta P, Mahoney D
J Pediatr Hematol Oncol
. 2016 Jun;
38(6):486-8.
PMID: 27306229
Vitamin B12 deficiency is a rare diagnosis in young children. We present the case of a 1-year-old Zimbabwean child with profound anemia. Further testing revealed undetectable levels of vitamin B12...
10.
Nelson N, Marcogliese A, Bergstrom K, Scheurer M, Mahoney D, Bertuch A
Pediatr Blood Cancer
. 2016 Apr;
63(8):1484-7.
PMID: 27100794
JAK2, MPL, and CALR mutations, which underlie essential thrombocythemia (ET) in most adults, are infrequent in children. Consequently, additional tests are needed to confirm pediatric ET diagnoses. We report a...